Combined rho kinase and renin-angiotensin system inhibition: a new therapeutic perspective for renal and cardiovascular remodeling.
Jalil
Jorge E
JE
Department of Cardiovascular Diseases, Pontificia Universidad Católica de Chile, Medical School, Marcoleta 367 Piso 8, Santiago, Chile. jjalil@med.puc.cl
Jalil
Roberto
R
Ocaranza
Maria Paz
MP
D000818:Animals; D006332:Cardiomegaly / Q000188:drug therapy*; D002317:Cardiovascular Agents / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000201:enzymology; D007674:Kidney Diseases / Q000188:drug therapy*; D051379:Mice; D009206:Myocardium / Q000201:enzymology; D051381:Rats; D012084:Renin-Angiotensin System / Q000187:drug effects*; D020257:Ventricular Remodeling / Q000187:drug effects*; D054460:rho-Associated Kinases / Q000037:antagonists & inhibitors*
D002317:Cardiovascular Agents; D054460:rho-Associated Kinases